President and CEO of Helius Medical Technologies Inc (HSDT) Philippe Deschamps bought 127,551 shares of HSDT on 12/22/2017 at an average price of $1.96 a share. The total cost of this purchase was $250,000.
Helius Medical Technologies Inc is engaged in the business of medical technology industry. The Company’s operations include the development, licensing and acquisition of non-invasive platform technologies. Helius Medical Technologies Inc has a market cap of $221.160 million; its shares were traded at around $2.25 .
CEO Recent Trades:
President and CEO Philippe Deschamps bought 127,551 shares of HSDT stock on 12/22/2017 at the average price of $1.96. The price of the stock has increased by 14.8% since.
CFO Recent Trades:
CFO and COO Joyce N Laviscount bought 79,082 shares of HSDT stock on 12/22/2017 at the average price of $1.96. The price of the stock has increased by 14.8% since.
Directors and Officers Recent Trades:
Director Blane Walter bought 382,653 shares of HSDT stock on 12/22/2017 at the average price of $1.96. The price of the stock has increased by 14.8% since.Director Dane Andreeff bought 255,101 shares of HSDT stock on 12/22/2017 at the average price of $1.96. The price of the stock has increased by 14.8% since.
For the complete insider trading history of HSDT, click here
.